With this (RFI) Notice, the NIH invites interested and knowledgeable persons to inform NIH about existing and desired approaches for measuring and assessing value of biomedical data repositories. This RFI has implications for “two general categories: 1) Deposition repositories, which support primary research data submitted by the data producers; and 2) Knowledgebases, which provide curated findings derived from the aggregation or analysis of experimental data.” Respondents are encouraged to describe what resources they use and how they use it, and how that community use/importance can be measured.   
​
A full description of the RFI is available at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-133.html

The PGx Tools page provides links to resources that provides links to resources that can interest researchers in the area of pharmacogenomics. Though not exhaustive, the list includes:

• genotype and sequencing results of over a million SNPs from different ethnic populations
• resources and portals related to mRNA and protein expression levels from multiple tissues; normal and cancer samples
• databases and resources used to link genomewide association studies with functional information
• databases for eQTL
• collections of data, software and tools useful for pharmacogenomics studies, which also includes summary statistics from various genomewide association studies
  ​
  

We welcome any comments and feedback about the list of pharmacogenomics resources. If we missed any of your favorite resources, please let us know. Comments can be sent to info@pgrn.org

The Pharmacogenomics Research Network (PGRN) is bringing together scientists who study the interactions between genomes and drug responses. This symposium, organized by the PGRN and open to all ASHG attendees and others, explores current topics in pharmacogenomics with sessions on innovative approaches for identifying genes that influence drug response, the role of pharmacogenomics in drug discovery, technologies used in pharmacogenomic studies, and the evolution of pharmacogenes.

In addition, there will be an interactive panel discussion with diverse stakeholders on issues affecting the clinical implementation of pharmacogenomic testing. This symposium will enable scientists from multiple disciplines to learn about work at the frontier of pharmacogenomics and identify new opportunities for advancing research in basic and translational pharmacogenomics.

Be sure to tune in for  Research In Progress Seminars (RIPS)
RIPS generally are broadcast on the first Friday of each month. All PGRN members are encouraged to attend.  
Click here for a schedule

October 14, 2016    
Dr. Naohiro Terada         
Stem Cell Research in The Era of Personal Genomics

November 18, 2016    
Dr. Michael Pacanowski         

December 9, 2016     
Dr. Mohamed Shahin      
​Pharmacometabolomics Complements Pharmacogenomics and Reveals Novel Signatures Associated with the Blood Pressure Response to Thiazide Diuretics